Standard-of-Care Control Groups in Breast Cancer Trials Often Not Standard, Study Says

Standard-of-Care Control Groups in Breast Cancer Trials Often Not Standard, Study Says
Many breast cancer clinical trials that are described as comparing a new treatment with a standard-of-care therapy do not actually make such a comparison, University of Sydney researchers argue. That’s because they fail to follow U.S. or European clinical practice guidelines on control treatments, the team contended. The risk of doing this is generating a biased

Knowledge is power when living with breast cancer.

Get access to the web’s leading Breast Cancer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

One comment

  1. Wanda Northam, MD says:

    In the day of MIS, data mining should be used to provide control groups for Triple Negative Breast Cancer and other cancers with poor or dismal prognoses and perhaps as well with metastatic breast cancers which we have long histories available of their morbidities/outcomes. It is high time research protocols enter the computer age.

Leave a Comment

Your email address will not be published. Required fields are marked *